Skip to content
Delee logo

Delee

Delee is a YC Winter 2017 (W17) company. Based in Monterrey, N.L., Mexico. Team of 18.

  • Medical Devices
  • Diagnostics

About Delee

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Delee builds a blood-based diagnostic device that detects and monitors cancer by isolating and analyzing circulating tumor cells. The device targets early-stage cancer diagnosis and ongoing treatment tracking, replacing or supplementing more invasive tissue biopsies and conventional lab workflows. Oncologists and diagnostic labs are the primary users.

From the Y Combinator listing

How Delee describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Blood testing device for early diagnosis of cancer and treatment…

Delee is a medical device company that developed a blood-testing device for early diagnosis of cancer and treatment monitoring through the isolation and analysis of the circulating tumor cells.

Facts

Industry
Healthcare / Healthcare -> Diagnostics
Location
Monterrey, N.L., Mexico
Team size
18
Status
Active
Stage
Early

Founders (3)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works